INTS Latest Press Releases

-- August 11, 2026 --

NeOnc Approaches a Major Biotech Inflection Point as tomorrow's Brain-Cancer Data is set to Collide with a Tight Float Globe Newswire 11:00 AM

Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update PRNewswire 7:31 AM

-- August 4, 2026 --

Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026 PRNewswire 8:00 AM

-- July 15, 2026 --

Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study) PRNewswire 7:45 AM

-- July 1, 2026 --

Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6 PRNewswire 8:00 AM

-- May 14, 2026 --

Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award PRNewswire 8:00 AM

-- May 7, 2026 --

Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update PRNewswire 4:06 PM

-- April 15, 2026 --

Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation PRNewswire 9:15 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software